Text Size
81 studies found for:    Open Studies | Expanded Access Studies

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Available PFO ACCESS Registry
Conditions: Patent Foramen Ovale;   Stroke
Intervention: Device: Device closure with the AMPLATZER PFO Occluder
2 Available Uridine Triacetate as an Antidote for Patients at Excess Risk of 5-Fluorouracil (5-FU) Toxicity Due to Overdosage or Impaired Elimination
Conditions: Toxicity Due to Chemotherapy;   Impaired 5FU Elimination
Intervention: Drug: uridine triacetate
3 Available Compassionate Use of Triheptanoin (C7) for Fatty Acid Oxidation Disorders
Conditions: Very Long-chain acylCoA Dehydrogenase (VLCAD) Deficiency;   Carnitine Palmitoyltransferase Deficiencies (CPT1, CPT2);   Mitochondrial Trifunctional Protein Deficiency;   Long-chain Hydroxyacyl-CoA Dehydrogenase Deficiency
Intervention: Drug: triheptanoin
4 Unknown † Technology Platform and System Construction of Clinical Evaluation Studies on New Drugs of Hematological Malignancy
Condition: Multiple Myeloma
Intervention: Drug: Bortezomib/Dexamethasone/Melphalan
5 Available Bivalirudin foR Acute Myocardial Infarction underGoing Angioplasty in CHinese patienTs.
Condition: Acute Myocardial Infarction
Intervention: Drug: Bivalirudin
6 Unknown † Comparison Study of Adjuvant Chemotherapy for Chinese Triple Negative Breast Cancer
Condition: Triple Negative Breast Cancer
Intervention: Drug: Paclitaxel Cisplatin
7 Available Compassionate Use of the Becker Expander/Breast Implant
Condition: Breast Reconstruction
Interventions: Device: Becker 50 Expander/Breast implant;   Device: Becker 25 Expander/Breast implant
8 Available To Validate the Specific Patterns of Magnetocardiography, a Non-invasive Non-contact Examination for Patients With Ischemic Heart Disease or Cardiac Arrhythmia
Condition: Arrhythmia
Intervention: Other: MCG
9 Available Compassionate Use of Stiripentol in Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: Stiripentol
10 Available A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome
Conditions: Diabetes;   CVD
Intervention: Drug: Rosuvastatin,SFC fenofibrate
11 Available Use of Eylea for the Treatment of an Optic Nerve Hemangioma
Condition: Retinal Hemangioma
Intervention: Drug: Aflibercept
12 Available Effects of High-intensity Interval Training in Patients in Hemodialysis
Conditions: Chronic Renal Disease;   Hemodialysis
Intervention: Other: exercise
13 Unknown † Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine
Condition: Lambert-Eaton Myasthenic Syndrome
Intervention: Drug: 3,4 diaminopyridine
14 Available A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma
Condition: Liver Cancer
Intervention: Device: Theraspheres
15 Available Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
Conditions: Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Chronic Myeloid Leukemia;   Myelodysplastic Syndrome;   Lymphomas;   Bone Marrow Failure;   Hemoglobinopathy;   Immune Deficiency;   Osteopetrosis;   Cytopenias;   White Blood Cell Abnormalities;   Red Blood Cell Abnormalities
Intervention: Biological: CD34+ enriched, T Cell Depleted donor stem cell product
16 Available Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD
Conditions: Graft vs Host Disease;   Graft-Versus-Host Disease
Intervention: Drug: Prochymal®
17 Available An Open-Label, Multicenter, Extension Study of NKTR-102 in Subjects Previously Enrolled in NKTR-102 Studies
Conditions: Malignant Solid Tumour;   Breast Cancer;   Ovarian Cancer;   Colorectal Cancer
Intervention: Drug: NKTR-102
18 Available Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C
Condition: Post-transplant Recurrent Hepatitis C
Intervention: Drug: Sofosbuvir + RIbavirin +/- Pegylated Interferon
19 Available An Open-Label, Multi-Center, Expanded Access Program With Eribulin for the Treatment of Advanced Breast Cancer Refractory
Condition: Metastatic Breast Cancer
Intervention: Drug: Eribulin Mesylate
20 Available Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Sirolimus;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Drug: Mycophenolic acid
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years